For individuals with type 2 diabetes, medications like Ozempic® (semaglutide) and Mounjaro are proving highly effective in managing blood sugar, reducing cardiovascular risk, and even slowing the progression of kidney disease – but the reasons why these drugs work so well for some patients and not others are becoming clearer.
Ozempic®, a GLP-1 receptor agonist, is approved by the Food and Drug Administration for multiple uses in adults with type 2 diabetes. It’s proven to lower blood sugar and A1C levels when used alongside diet and exercise. The medication also reduces the risk of major cardiovascular events, such as stroke and heart attack, in patients with existing heart disease, and lowers the risk of worsening kidney disease in those with chronic kidney disease.
The initial dose of Ozempic® is 0.25 mg administered once weekly for the first four weeks, allowing the body to adjust to the medication. After five weeks, healthcare professionals typically increase the dosage to 0.5 mg weekly. For individuals with chronic kidney disease, a further increase to 1 mg may be recommended after at least four weeks at the 0.5 mg dose.
The medication is available in pens that deliver doses of 1 mg or 2 mg, providing additional A1C control as needed. The maximum dose is 2 mg once a week, and it should always be taken as prescribed by a healthcare professional, with or without food.
According to patient testimonials featured by the manufacturer, some individuals have experienced noticeable weight loss and lowered A1C levels while taking Ozempic®.
“With Ozempic®, I lowered my A1C and saw noticeable weight loss,” said Michael, a patient featured in promotional materials for the drug.
It’s important to note that Ozempic® is not specifically a weight-loss drug, although clinical studies have shown that adults taking the medication have lost an average of 7.1 to 14.1 pounds. Although, weight changes can vary, with some individuals experiencing weight gain.
These findings highlight the potential of GLP-1 receptor agonists to address multiple health concerns associated with type 2 diabetes, offering a comprehensive approach to managing the condition and improving patient outcomes. Individuals considering Ozempic® are encouraged to discuss their specific needs and health status with their healthcare provider to determine if it is the right treatment option for them.
More information about Ozempic® dosing and frequently asked questions can be found on the official Ozempic® website.
